Cilostazol in patients with ischemic stroke

10.1016/S1474-4422(10)70198-8

Liu Y, 2001, Cardiovasc Drug Rev, 19, 369, 10.1111/j.1527-3466.2001.tb00076.x

Honda F, 2006, Stroke, 37, 223, 10.1161/01.STR.0000196977.76702.6d

10.1016/S1474-4422(10)70038-7

Fumio Gotoh HT, 2000, J Stroke Cerebrovasc Dis, 9, 147, 10.1053/jscd.2000.7216

Nakamura T, 2007, Thromb Res, 119, 511, 10.1016/j.thromres.2006.05.005

Goto S, 2005, Atheroscler Suppl, 6, 3, 10.1016/j.atherosclerosissup.2005.09.002

Omi H, 2004, Microvasc Res, 68, 119, 10.1016/j.mvr.2004.05.002

Kitamoto S, 2002, J Atheroscler Thromb, 9, 261, 10.5551/jat.9.261

Cojocaru IM, 2010, Rom J Intern Med, 48, 101

Hong KW, 2006, Curr Pharm Des, 12, 565, 10.2174/138161206775474323

Nonaka Y, 2009, J Pharmacol Exp Ther, 330, 13, 10.1124/jpet.109.151548

Suzuki S, 2007, Biol Pharm Bull, 30, 791, 10.1248/bpb.30.791

Hiratsuka M, 2007, Drug Metab Dispos, 35, 1730, 10.1124/dmd.107.016758

Yoo HD, 2009, Clin Pharmacol Ther, 86, 281, 10.1038/clpt.2009.90

Lee SP, 2010, Trials, 11, 87, 10.1186/1745-6215-11-87

CAPRIE Steering Committee, 1996, Lancet, 348, 1329, 10.1016/S0140-6736(96)09457-3

Hass WK, 1989, N Engl J Med, 321, 501, 10.1056/NEJM198908243210804

Lee JH, 2010, Eur J Neurol, 17, 434, 10.1111/j.1468-1331.2009.02837.x

Huang Y, 2008, Lancet Neurol, 7, 494, 10.1016/S1474-4422(08)70094-2

10.1161/01.STR.0000157667.06542.b7

Yamasaki Y, 2006, Cardiovasc Diabetol, 5, 16, 10.1186/1475-2840-5-16

10.1016/j.ahj.2009.01.006

Ge J, 2005, J Cardiovasc Pharmacol, 46, 162, 10.1097/01.fjc.0000167012.82930.8f

Takigawa T, 2010, J Vasc Surg, 51, 51, 10.1016/j.jvs.2009.08.040